Mark Topazian

18.8k citations
288 papers · 10.5k indexed · 3 hit papers · h-index 52

Impact in

  • Surgery top 0.1%
    • Pancreatitis Pathology and Treatment
    • Gastrointestinal disorders and treatments
    • Pediatric Hepatobiliary Diseases and Treatments
    • Esophageal and GI Pathology
  • Rheumatology top 0.2%
    • IgG4-Related and Inflammatory Diseases

Papers in

    • Pancreatitis Pathology and Treatment 101
    • Esophageal and GI Pathology 55
    • Gastrointestinal disorders and treatments 42
    • Pediatric Hepatobiliary Diseases and Treatments 41
    • Cholangiocarcinoma and Gallbladder Cancer Studies 24
    • Pancreatic and Hepatic Oncology Research 108

Mark Topazian

274 papers receiving 10.2k citations

Hit Papers

Rituximab for IgG4-related disease: a prospective, open-label trial 2015 · 444 citations
4442006202620122019200400600

Peers

Mark Topazian
Comparison fields: 5 of 127
  • Surgery 8.6k
  • Rheumatology 2.8k
  • Oncology 4.1k
  • Pulmonary and Respiratory Medicine 3.6k
  • Gastroenterology 468
Replace Bruce G. Wolff with:
Bruce G. Wolff United States
Neil Hyman United States
Ian C. Lavery United States
Luca Frulloni Italy
Roger R. Dozois United States
Juan J. Nogueras United States
Robert D. Madoff United States
Elizabeth Rajan United States
J C Goligher United Kingdom
N J McC Mortensen United Kingdom
Mark Topazian relative to Bruce G. Wolff United States Bruce G. Wolff's profile →
Citations per field
00.5×
Bruce G. Wolff · 1×
Citations per year

Countries citing papers authored by Mark Topazian

Since Specialization
Citations

This map shows the geographic impact of Mark Topazian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Topazian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Topazian more than expected).

Fields of papers citing papers by Mark Topazian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Topazian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Topazian. The network helps show where Mark Topazian may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark Topazian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Topazian Line = papers co-authored together Mark Topazian links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20243
3 20240
4 20235
5 20234
6 202315
7 20227
8 202120
9 2017151
10 201680
11 201626
12 201525
13 2012119
14 201213
15 200946
16 200948
17 200528
18 200413
19 200411
20 19956

About Mark Topazian

Mark Topazian is a scholar working on Surgery, Oncology, Pulmonary and Respiratory Medicine, Gastroenterology and Hepatology, having authored 288 papers that have together received 10.5k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (108 papers), Pancreatitis Pathology and Treatment (101 papers), Gallbladder and Bile Duct Disorders (76 papers), Esophageal and GI Pathology (55 papers), Gastrointestinal disorders and treatments (42 papers), Pediatric Hepatobiliary Diseases and Treatments (41 papers), Neuroendocrine Tumor Research Advances (29 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (24 papers). The work is most often cited by research in Surgery (8.6k citations), Rheumatology (2.8k citations), Oncology (4.1k citations), Pulmonary and Respiratory Medicine (3.6k citations) and Gastroenterology (468 citations). Mark Topazian has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Suresh T. Chari, Bret T. Petersen, Jonathan E. Clain, Randall K. Pearson, Thomas C. Smyrk, Naoki Takahashi, Todd H. Baron, Michael J. Levy, Santhi Swaroop Vege and Michael J. Levy. Their work appears in journals such as Gastrointestinal Endoscopy, Clinical Gastroenterology and Hepatology, Gastroenterology, The American Journal of Gastroenterology and Endoscopy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026